You have 9 free searches left this month | for more free features.

Rasagiline

Showing 1 - 25 of 69

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

REM Sleep Behavior Disorder, Parkinson Disease, Synucleinopathies Trial (Rasagiline)

Not yet recruiting
  • REM Sleep Behavior Disorder
  • +2 more
  • Rasagiline
  • (no location specified)
Nov 6, 2022

Results Survey "Survey on Long-term Safety"

Completed
  • Parkinson's Disease
  • Rasagiline
  • Tokyo, Japan
    Takeda Selected Site
Nov 2, 2021

Depressive Symptoms, Parkinson's Disease Trial in Italy (Rasagiline, Placebo)

Completed
  • Depressive Symptoms
  • Parkinson's Disease
  • Rasagiline
  • Placebo
  • Cagliari, Italy
  • +11 more
Aug 30, 2021

Safinamide, Rasagiline and Other Standard of Care in PD

Recruiting
  • Parkinson's Disease
    • Berlin, Germany
    • +2 more
    Aug 9, 2021

    Parkinson's Disease Trial in Gainesville (drug, other, device)

    Active, not recruiting
    • Parkinson's Disease
    • Rasagiline
    • +4 more
    • Gainesville, Florida
      Laboratory for Rehabilitation Neuroscience
    Nov 12, 2021

    Parkinson's Disease Trial in United States (Rasagiline, Placebo)

    Completed
    • Parkinson's Disease
    • Rasagiline
    • Placebo
    • Birmingham, Alabama
    • +39 more
    Nov 6, 2021

    Alzheimer's Disease Trial in Las Vegas, Cleveland, Lakewood (Rasagiline, Placebo)

    Completed
    • Alzheimer's Disease
    • Rasagiline
    • Placebo
    • Las Vegas, Nevada
    • +2 more
    Oct 21, 2020

    Amyotrophic Lateral Sclerosis (ALS) Trial in United States (Rasagiline, Placebo)

    Completed
    • Amyotrophic Lateral Sclerosis (ALS)
    • Rasagiline
    • Placebo
    • Phoenix, Arizona
    • +9 more
    Jan 14, 2020

    Parkinson Disease Trial in Roma (Safinamide)

    Completed
    • Parkinson Disease
    • Roma, Italy
      IRCCS San Raffaele
    Oct 10, 2019

    Schizophrenia Trial in Baltimore, Catonsville, Dundalk (rasagiline (Pharmacodynamics), Placebo)

    Completed
    • Schizophrenia
    • rasagiline (Pharmacodynamics)
    • Placebo
    • Baltimore, Maryland
    • +4 more
    Sep 23, 2019

    Parkinson Disease, Early Parkinson's Disease Trial in Worldwide (P2B001, Rasagiline, Pramipexole)

    Active, not recruiting
    • Parkinson Disease
    • Early Parkinson's Disease
    • Scottsdale, Arizona
    • +71 more
    May 20, 2021

    MDD, Treatment Resistant Depression Trial in Toronto ([11C]SL25.1188 PET radiotracer)

    Recruiting
    • Major Depressive Disorder
    • Treatment Resistant Depression
    • [11C]SL25.1188 PET radiotracer
    • Toronto, Ontario, Canada
      CAMH
    Mar 31, 2022

    Healthy Volunteers Trial in Anaheim (Placebo, Rasigiline, Phenelzine)

    Recruiting
    • Healthy Volunteers
    • Placebo
    • +3 more
    • Anaheim, California
      Anaheim Clinical Trials
    Oct 13, 2021

    2.5 Years of Rasagiline Therapy on Progression of Cognitive

    Completed
    • Parkinson's Disease
    • Rasagiline
    • Buffalo, New York
      University at Buffalo
    Apr 14, 2019

    Retinal Detachment Trial in Bern (Rasagiline, Placebo)

    Terminated
    • Retinal Detachment
    • Rasagiline
    • Placebo
    • Bern, Switzerland
      Department of Ophthalmology, Bern University Hospital
    Feb 18, 2019

    Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)

    Enrolling by invitation
    • Parkinson Disease
    • Treatment Adherence
    • Ankara, Turkey
      Ankara Atatürk Sanatorium Training and Research Hospital
    Oct 30, 2023

    Parkinson's Disease Trial in China (Placebo, Azilect®)

    Completed
    • Parkinson's Disease
    • Beijing, China
    • +17 more
    Aug 10, 2018

    Parkinson Disease, Multiple System Atrophy, Progressive Supranuclear Palsy Trial in Loma Linda (Droxidopa, Placebo Oral Tablet)

    Withdrawn
    • Parkinson Disease
    • +2 more
    • Loma Linda, California
      Loma Linda University Faculty Medical Offices - Neurology Clinic
    Feb 14, 2022

    Parkinson Disease Trial in China (Selegiline)

    Completed
    • Parkinson Disease
    • Changshu, Jiangsu, China
    • +3 more
    May 5, 2021

    Amyotrophic Lateral Sclerosis (ALS) Trial in Canada, United States (rasagiline)

    Completed
    • Amyotrophic Lateral Sclerosis (ALS)
    • rasagiline
    • Phoenix, Arizona
    • +9 more
    Apr 17, 2018

    Amyotrophic Lateral Sclerosis (ALS) Trial in Dallas (Antioxidants)

    Recruiting
    • Amyotrophic Lateral Sclerosis (ALS)
    • Antioxidants
    • Dallas, Texas
      VA North Texas Health Care System
    Mar 25, 2022

    Multiple System Atrophy Trial in London (Exenatide Pen Injector [Bydureon])

    Recruiting
    • Multiple System Atrophy
    • Exenatide Pen Injector [Bydureon]
    • London, United Kingdom
      Leonard Wolfson Experimental Neurology Centre, National Hospital
    Nov 4, 2020

    ALS Trial in Kansas City (Oxaloacetic Acid)

    Unknown status
    • ALS
    • Oxaloacetic Acid
    • Kansas City, Kansas
      University of Kansas Medical Center
    Dec 17, 2019

    Parkinson's Disease Trial in Israel, United States (P2B001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),, Placebo,

    Completed
    • Parkinson's Disease
    • P2B001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),
    • +2 more
    • Birmingham, Alabama
    • +28 more
    Oct 30, 2017

    Azilect + Antidepressant Chart Review

    Completed
    • Serotonin Syndrome
    • Group R+AD Rasagiline + Antidepressant
    • +2 more
    • (no location specified)
    Feb 2, 2017